Indole‐3‐Carboxaldehyde Inhibits Inflammatory Response and Lipid Accumulation in Macrophages Through the miR ‐1271‐5p/ HDAC9 Pathway
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.70263 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Wei Luo und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital, Department of Cardiology, Hengyang Medical School, University of South China, Hengyang, Hunan, China. Hauptthemen laut MEDLINE: MicroRNAs, Histone Deacetylases, Indoles, ATP Binding Cassette Transporter 1. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Scientific Research Project of Hunan Provincial Health Commission, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Indole‐3‐carboxaldehyde (ICA), a microbiota‐derived tryptophan metabolite, has been reported to protect against atherosclerosis. However, the molecular mechanisms for its atheroprotective effect remain largely unknown. This study aimed to explore the influence of ICA on lipid accumulation and inflammatory response in THP‐1 macrophage‐derived foam cells. Our results showed that administration of ICA upregulated the expression of miR‐1271‐5p, ATP binding cassette transporter A1 (ABCA1) and ABCG1, downregulated histone deacetylase 9 (HDAC9) expression and inhibited macrophage lipid accumulation. ICA treatment also facilitated macrophage polarisation to the M2 phenotype and alleviated inflammatory response, as evidenced by decreased IL‐6 levels and increased IL‐10 levels. HDAC9 was identified as a direct target of miR‐1271‐5p. HDAC9 overexpression or miR‐1271‐5p knockdown decreased the effect of ICA on ABCA1 and ABCG1 expression as well as inflammatory response. Taken together, these results suggest that ICA can suppress lipid accumulation and mitigate inflammatory response in macrophages by activating the miR‐1271‐5p/HDAC9 signalling cascade, thereby providing new explanations for how ICA reduces atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital, Department of Cardiology, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
- The First Affiliated Hospital, Department of Function, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
- Institute of Clinical Medicine, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
- School of Medical and Pharmacological Technology, Hunan Polytechnic of Environment and Biology, Hengyang, Hunan, China.
ORCID-Profile: Wei Luo
Förderung
- National Natural Science Foundation of China
- Scientific Research Project of Hunan Provincial Health Commission
- Natural Science Foundation of Hunan Province
Zitieren
APA
Luo, W., Meng, J., Yu, X. H., Zhang, Z. Z., Wang, G., & He, J. (2024). Indole‐3‐Carboxaldehyde Inhibits Inflammatory Response and Lipid Accumulation in Macrophages Through the miR ‐1271‐5p/ HDAC9 Pathway. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70263
Vancouver
Luo W, Meng J, Yu XH, Zhang ZZ, Wang G, He J. Indole‐3‐Carboxaldehyde Inhibits Inflammatory Response and Lipid Accumulation in Macrophages Through the miR ‐1271‐5p/ HDAC9 Pathway. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70263
BibTeX
@article{Luo2024,
author = {Luo, Wei and Meng, Jun and Yu, Xiao-Hua and Zhang, Zi-Zhen and Wang, Gang and He, Jin},
title = {Indole‐3‐Carboxaldehyde Inhibits Inflammatory Response and Lipid Accumulation in Macrophages Through the miR ‐1271‐5p/ HDAC9 Pathway},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.70263}
}
EUVIMED